These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1183242)

  • 1. Uptake of 5-iododeoxyuridine as a measure of tumor growth and tumor inhibition.
    Bonmassar E; Houchens DP; Fioretti MC; Goldin A
    Chemotherapy; 1975; 21(6):321-9. PubMed ID: 1183242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune inhibition of allogeneic lymphoma cells in the peritoneal cavity of mice.
    Fioretti MC; Libarati M; Bonmassar E; Cudkowicz G
    Cancer Res; 1975 Jan; 35(1):30-6. PubMed ID: 1089042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effector cell stimulation-inhibition of in vitro lymphoma cell DNA synthesis and correlation with in vivo antitumor response.
    Gordon WC; Prager MD
    Cancer Res; 1977 Feb; 37(2):507-13. PubMed ID: 832275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of antilymphoma allograft response in normal and lethally irradiated mice by cyclophosphamide (NSC-26271) and isophosphamide (NSC-109724).
    Houchens DP; Iorio A; Barzi A; Goldin A; Bonmassar E
    Cancer Chemother Rep; 1975; 59(5):967-73. PubMed ID: 1203899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localized incorporation of iododeoxyuridine from polycation-complexed iododeoxycytidylic acid into DNA of several murine and hamster tumors.
    Woodman RJ
    Cancer Res; 1968 Oct; 28(10):2007-16. PubMed ID: 5696932
    [No Abstract]   [Full Text] [Related]  

  • 6. [Distribution and elimination of transplanted sarcoma JWS and leukemia L1210 cells in allogeneic recipients--inbred C57BL mice by intravenous route].
    Skierska E; Skierski JS
    Med Dosw Mikrobiol; 1991; 43(3-4):161-5. PubMed ID: 1823379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood thymidine level and iododeoxyuridine incorporation and reutilization in DNA in mice given long-acting thymidine pellets.
    Lee DJ; Prensky W; Krause G; Hughes WL
    Cancer Res; 1976 Dec; 36(12):4577-83. PubMed ID: 1000502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adriamycin and daunorubicin: a comparison of antitumor activities and tissue uptake in mice following immunosuppression.
    Schwartz HS; Grindey GB
    Cancer Res; 1973 Aug; 33(8):1837-44. PubMed ID: 4720795
    [No Abstract]   [Full Text] [Related]  

  • 9. Loss of marrow allograft resistance in mice with transplanted methylcholanthrene-induced sarcomas.
    Kumar V; Bennett M
    J Natl Cancer Inst; 1975 Aug; 55(2):489-92. PubMed ID: 240033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transplantation resistance of drug-treated allogeneic mice against murine lymphomas--II. Studies with various tumor-host combinations.
    Bonmassar A; Rivosecchi-Merletti P; Barzi A; Goldin A; Bonmassar E
    Int J Immunopharmacol; 1981; 3(4):391-9. PubMed ID: 7333720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Duration of inhibition of synthesis of DNA in tumors and host tissues after single doses of nitrosoureas.
    Wheeler GP; Alexander JA
    Cancer Res; 1974 Aug; 34(8):1957-64. PubMed ID: 4842249
    [No Abstract]   [Full Text] [Related]  

  • 12. Incorporation of a potent antileukemic agent, 5-aza-2'-deoxycytidine, into DNA of cells from leukemic mice.
    Veselý J; Cihák A
    Cancer Res; 1977 Oct; 37(10):3684-9. PubMed ID: 71199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The inhibition of DNA synthesis by cannabinoids.
    Carchman RA; Harris LS; Munson AE
    Cancer Res; 1976 Jan; 36(1):95-100. PubMed ID: 1248011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism and selective effects of 1-beta-D-arabinofuranosylcytosine in L1210 and Host tissues in vivo.
    Chou TC; Hutchinson DJ; Schmid FA; Philips FS
    Cancer Res; 1975 Jan; 35(1):225-36. PubMed ID: 1109791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Murine leukemia growth inhibition or enhancement following immunization with tumor cells antigenically altered by drug treatment.
    Riccardi C; Giampietri A; Puccetti P; Biancifiori F; Fioretti MC
    Pharmacol Res Commun; 1977 Apr; 9(4):349-58. PubMed ID: 141049
    [No Abstract]   [Full Text] [Related]  

  • 16. Transformation of spleen cells three hours after infection in vivo with Friend leukemia virus.
    Rossi GB; Cudkowicz G; Friend C
    J Natl Cancer Inst; 1973 Jan; 50(1):249-54. PubMed ID: 4692865
    [No Abstract]   [Full Text] [Related]  

  • 17. Incorporation of iododeoxyuridine-125-I into the DNA of L1210 leukemia cells during tumor development.
    Her KG; Hughes WL
    Cancer Res; 1970 Jan; 30(1):236-43. PubMed ID: 5458962
    [No Abstract]   [Full Text] [Related]  

  • 18. [Kinetics and distribution of transplanted sarcoma JWS and leukemia L1210 cells by intravenous route].
    Skierska E; Skierski JS
    Med Dosw Mikrobiol; 1991; 43(3-4):153-60. PubMed ID: 1823378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural resistance of mice pretreated with 5-(3,3'-dimethyl-1-triazeno)-imidazole-4-carboxamide (DTIC) + cyclophosphamide (Cy) against virus-induced lymphoma cells.
    Campanile F; Iorio AM; Bonmassar E
    Int J Immunopharmacol; 1984; 6(4):251-8. PubMed ID: 6480192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Disruption of DNA synthesis and structure of mouse L1210 leukemia cells, sensitive and resistant to 1-methyl-1 nitrosourea and 1,3-bis(2-chloroethyl)-1-nitrosourea in vivo].
    Kukushkina GV; Peretolchina NM; Minenkova EA; Verovskiĭ VN; Sof'ina ZP
    Biokhimiia; 1984 Jul; 49(7):1189-98. PubMed ID: 6477985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.